Index by author

August 2022; Volume 42,Issue 8

  1. Adelstein, DAVID J.

    1. Open Access
      A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer
      TIMOTHY D. SMILE, CHANDANA A. REDDY, BRIAN MATIA, CHRISTOPHER W. FLEMING, CHAIM DOMB, JESSICA L. GEIGER, NIKHIL P. JOSHI, NEIL M. WOODY, DEBORAH J. CHUTE, CHRISTOPHER C. GRIFFITH, DAVID J. ADELSTEIN and SHLOMO A. KOYFMAN
      Anticancer Research August 2022, 42 (8) 3845-3852; DOI: https://doi.org/10.21873/anticanres.15875

  2. Ahle, GUIDO

    1. Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study
      XAVIER CHODERLOS DE LACLOS, DIDIER FRAPPAZ, GUIDO AHLE, CHARLOTTE BRONNIMANN, ISABELLE CATRY-THOMAS, ANTHONY JONCOUR, FRANCOIS GHIRINGHELLI and ELODIE VAULEON
      Anticancer Research August 2022, 42 (8) 3863-3867; DOI: https://doi.org/10.21873/anticanres.15878

  3. Akagi, YOSHITO

    1. Fatty Liver Does Not Increase the Risk of Postoperative Liver Damage Following Hepatectomy
      YORIKO NOMURA, JUN AKIBA, HIROHISA YANO, YOSHITO AKAGI and TORU HISAKA
      Anticancer Research August 2022, 42 (8) 4159-4164; DOI: https://doi.org/10.21873/anticanres.15915
    2. Open Access
      Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction – A Single Center Retrospective Study
      DAISUKE MUROYA, HIROTOSHI TSURU, HISAAKI SHIMOKOBE, YUICHI NAGAO, YASUNORI YOSHIMOTO, YOSHITO WADA, KOUJI HAYASHI, SATOSHI TANIWAKI, RYUTA MIDORIKAWA, SHINICHI TANIWAKI, SATOKI KOJIMA, SHOICHIRO ARAI, TAKAHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, MUNEHIRO YOSHITOMI, TORU HISAKA, YOSHITO AKAGI and KOJI OKUDA
      Anticancer Research August 2022, 42 (8) 4063-4070; DOI: https://doi.org/10.21873/anticanres.15903
    3. Significance of Intraperitoneal-free KRT20 and CEACAM6 mRNA Expression for Peritoneal Recurrence of Gastric Cancer
      HIDEAKI KAKU, KEISHIRO AOYAGI, TOMOYA SUDO, YUYA TANAKA, TAIZAN MINAMI, TARO ISOBE, JUNYA KIZAKI, YUKI UMETANI, NAOTAKA MURAKAMI, FUMIHIKO FUJITA and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4003-4010; DOI: https://doi.org/10.21873/anticanres.15896
    4. Open Access
      Chitinase 3-like 1, Carcinoembryonic Antigen-related Cell Adhesion Molecule 6, and Ectopic Claudin-2 in the Carcinogenic Processes of Ulcerative Colitis
      TETSUSHI KINUGASA, TOSHIYUKI TSUNODA, EMIKO MIZOGUCHI, TOSHIYUKI OKADA, TOMOYA SUDO, AKIHIKO KAWAHARA, JUN AKIBA and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4119-4127; DOI: https://doi.org/10.21873/anticanres.15910
    5. Open Access
      Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer
      GOICHI NAKAYAMA, TORU HISAKA, HISAMUNE SAKAI, MASANORI AKASHI, GOTO YUICHI, TOSHIHIRO SATO, YOSHIKI NAITO, JUN AKIBA, HIROHISA YANO and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4079-4087; DOI: https://doi.org/10.21873/anticanres.15905
    6. Open Access
      Hematogenous Dissemination of Tumor Cells in Hepatocellular Carcinoma: Comparing Anterior and Non-anterior Approach Hepatectomy
      SHIN SASAKI, YORIKO NOMURA, TOMOYA SUDO, HISAMUNE SAKAI, TORU HISAKA, JUN AKIBA, OSAMU NAKASHIMA, HIROHISA YANO, MASAYOSHI KAGE, YOSHITO AKAGI and KOJI OKUDA
      Anticancer Research August 2022, 42 (8) 4129-4137; DOI: https://doi.org/10.21873/anticanres.15911
    7. Experimental Exploration for Genes Related to Susceptibility and Resistance to Irinotecan
      SUGURU OGATA, TOMOYA SUDOU, FUMIHIKO FUJITA, TAKEFUMI YOSHIDA, KENICHI KOUSHI, TAKASHI NOGUCHI, JUNYA FUKUDA, NANAE OGATA, YOSHITAKA NOBUKUNI and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4011-4016; DOI: https://doi.org/10.21873/anticanres.15897
    8. Efficacy and Safety of Monthly Minodronate Therapy in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
      NANAE OGATA, UHI TOH, TOMOYA SUDOU, SUGURU OGATA, YUKO TAKAO, RIE SUGIHARA, HIDEAKI WATANABE, SHUNTARO MATUSHIMA and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4139-4143; DOI: https://doi.org/10.21873/anticanres.15912
    9. Open Access
      Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
      NOBUHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, SHOGO FUKUTOMI, MASANORI AKASHI, TOSHIHIRO SATO, YOSHITO AKAGI, KOJI OKUDA and TORU HISAKA
      Anticancer Research August 2022, 42 (8) 4089-4095; DOI: https://doi.org/10.21873/anticanres.15906
    10. Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
      YOSHIKI NAITO, JUN AKIBA, YOSHINAO KINJO, EIJI SADASHIMA, TOSHIRO OGATA, YUTA YANO, MASAHIKO TANIGAWA, MASAMICHI NAKAYAMA, AKIHIKO KAWAHARA, YOSHINOBU OKABE, HISAMUNE SAKAI, TORU HISAKA, YOSHITO AKAGI and HIROHISA YANO
      Anticancer Research August 2022, 42 (8) 4145-4151; DOI: https://doi.org/10.21873/anticanres.15913

  4. Akamine, YUTA

    1. MR Prediction of Malignant Switch With the Cyst Fluid’s T2 Value in Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Preliminary Study
      SEIICHIRO TAKAO, AKIHIRO NISHIE, YASUHIRO USHIJIMA, YUKIHISA TAKAYAMA, KOICHIRO MORITA, KEISUKE ISHIMATSU, YUTAKA KOGA, YASUHISA MORI, YUTA AKAMINE and KOUSEI ISHIGAMI
      Anticancer Research August 2022, 42 (8) 3895-3903; DOI: https://doi.org/10.21873/anticanres.15883

  5. Akashi, MASANORI

    1. Open Access
      Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer
      GOICHI NAKAYAMA, TORU HISAKA, HISAMUNE SAKAI, MASANORI AKASHI, GOTO YUICHI, TOSHIHIRO SATO, YOSHIKI NAITO, JUN AKIBA, HIROHISA YANO and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4079-4087; DOI: https://doi.org/10.21873/anticanres.15905
    2. Open Access
      Liberal Application of Portal Vein Embolization for Right Hepatectomy Against Hepatocellular Carcinoma: Strategy to Achieve Zero Mortality for a Damaged Liver
      NOBUHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, SHOGO FUKUTOMI, MASANORI AKASHI, TOSHIHIRO SATO, YOSHITO AKAGI, KOJI OKUDA and TORU HISAKA
      Anticancer Research August 2022, 42 (8) 4089-4095; DOI: https://doi.org/10.21873/anticanres.15906

  6. Akiba, JUN

    1. Fatty Liver Does Not Increase the Risk of Postoperative Liver Damage Following Hepatectomy
      YORIKO NOMURA, JUN AKIBA, HIROHISA YANO, YOSHITO AKAGI and TORU HISAKA
      Anticancer Research August 2022, 42 (8) 4159-4164; DOI: https://doi.org/10.21873/anticanres.15915
    2. Open Access
      Chitinase 3-like 1, Carcinoembryonic Antigen-related Cell Adhesion Molecule 6, and Ectopic Claudin-2 in the Carcinogenic Processes of Ulcerative Colitis
      TETSUSHI KINUGASA, TOSHIYUKI TSUNODA, EMIKO MIZOGUCHI, TOSHIYUKI OKADA, TOMOYA SUDO, AKIHIKO KAWAHARA, JUN AKIBA and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4119-4127; DOI: https://doi.org/10.21873/anticanres.15910
    3. Open Access
      Tumour Budding as an Independent Prognostic Factor for Survival in Patients With Distal Bile Duct Cancer
      GOICHI NAKAYAMA, TORU HISAKA, HISAMUNE SAKAI, MASANORI AKASHI, GOTO YUICHI, TOSHIHIRO SATO, YOSHIKI NAITO, JUN AKIBA, HIROHISA YANO and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4079-4087; DOI: https://doi.org/10.21873/anticanres.15905
    4. Open Access
      Hematogenous Dissemination of Tumor Cells in Hepatocellular Carcinoma: Comparing Anterior and Non-anterior Approach Hepatectomy
      SHIN SASAKI, YORIKO NOMURA, TOMOYA SUDO, HISAMUNE SAKAI, TORU HISAKA, JUN AKIBA, OSAMU NAKASHIMA, HIROHISA YANO, MASAYOSHI KAGE, YOSHITO AKAGI and KOJI OKUDA
      Anticancer Research August 2022, 42 (8) 4129-4137; DOI: https://doi.org/10.21873/anticanres.15911
    5. Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma
      YOSHIKI NAITO, JUN AKIBA, YOSHINAO KINJO, EIJI SADASHIMA, TOSHIRO OGATA, YUTA YANO, MASAHIKO TANIGAWA, MASAMICHI NAKAYAMA, AKIHIKO KAWAHARA, YOSHINOBU OKABE, HISAMUNE SAKAI, TORU HISAKA, YOSHITO AKAGI and HIROHISA YANO
      Anticancer Research August 2022, 42 (8) 4145-4151; DOI: https://doi.org/10.21873/anticanres.15913

  7. Aoki, YUSUKE

    1. Open Access
      Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet
      YUTARO KUBOTA, QINGHONG HAN, KAZUYUKI HAMADA, YUSUKE AOKI, NORIYUKI MASAKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
      Anticancer Research August 2022, 42 (8) 3857-3861; DOI: https://doi.org/10.21873/anticanres.15877

  8. Aoyagi, KEISHIRO

    1. Significance of Intraperitoneal-free KRT20 and CEACAM6 mRNA Expression for Peritoneal Recurrence of Gastric Cancer
      HIDEAKI KAKU, KEISHIRO AOYAGI, TOMOYA SUDO, YUYA TANAKA, TAIZAN MINAMI, TARO ISOBE, JUNYA KIZAKI, YUKI UMETANI, NAOTAKA MURAKAMI, FUMIHIKO FUJITA and YOSHITO AKAGI
      Anticancer Research August 2022, 42 (8) 4003-4010; DOI: https://doi.org/10.21873/anticanres.15896

  9. Aoyama, TORU

    1. Phase II Study of a Multi-center Randomized Controlled Trial to Evaluate Oral Vitamin B12 Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients
      TORU AOYAMA, YUKIO MAEZAWA, HARUHIKO CHO, YUSUKE SAIGUSA, JUN TAMURA, KAZUHITO TSUCHIDA, KEISUKE KOMORI, KAZUKI KANO, KENKI SEGAMI, KENTARO HARA, KOTARO SENUKI, YOSHIHIRO SUZUKI, MICHIYO YAMAKAWA, HIROSHI TAMAGAWA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
      Anticancer Research August 2022, 42 (8) 3963-3970; DOI: https://doi.org/10.21873/anticanres.15891
    2. The Albumin–Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment
      MIWHA JU, TORU AOYAMA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, JUNYA MORITA, ATSUSHI ONODERA, KAZUYA ENDO, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, MASATO NAKAZONO, KENKI SEGAMI, TETSUSHI ISHIGURO, SHIZUNE ONUMA, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
      Anticancer Research August 2022, 42 (8) 3929-3935; DOI: https://doi.org/10.21873/anticanres.15887
    3. Clinical Significance of EREG Gene Expression in Gastric Cancer Tissue After Curative Surgery
      HIDEAKI SUEMATSU, ITARU HASHIMOTO, YUKIHIKO HIROSHIMA, HAYATO WATANABE, KAZUKI KANO, KOSUKE TAKAHASHI, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TAKASHI OGATA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, YOHEI MIYAGI and TAKASHI OSHIMA
      Anticancer Research August 2022, 42 (8) 3873-3878; DOI: https://doi.org/10.21873/anticanres.15880

  10. Arai, SHOICHIRO

    1. Open Access
      Salvage PTBD With Chemotherapy Improves Survival in Patients With Unresectable Malignant Biliary Obstruction – A Single Center Retrospective Study
      DAISUKE MUROYA, HIROTOSHI TSURU, HISAAKI SHIMOKOBE, YUICHI NAGAO, YASUNORI YOSHIMOTO, YOSHITO WADA, KOUJI HAYASHI, SATOSHI TANIWAKI, RYUTA MIDORIKAWA, SHINICHI TANIWAKI, SATOKI KOJIMA, SHOICHIRO ARAI, TAKAHISA SHIRAHAMA, YUICHI GOTO, HISAMUNE SAKAI, MUNEHIRO YOSHITOMI, TORU HISAKA, YOSHITO AKAGI and KOJI OKUDA
      Anticancer Research August 2022, 42 (8) 4063-4070; DOI: https://doi.org/10.21873/anticanres.15903
« Previous (Pages : 1 2 3 4 5 6 ... 40) Next »
Back to top

In this issue